Skip to main content

Month: April 2021

Brookfield Infrastructure Encourages Inter Pipeline to Increase Transparency and Put Shareholders First

More than 75 days have passed since Brookfield Infrastructure announced its intention to make the Offer, and yet the IPL Special Committee has not provided shareholders with any real update regarding the Strategic Review process   IPL’s recent update on the Heartland Petrochemical Complex raises many more questions than it answers; the Company has been challenged to identify a partner for this project since commencement of a process in late 2019 Based on the current trading price of Brookfield Infrastructure Corporation (NYSE: BIPC; TSX: BIPC) class A exchangeable shares as of market close on April 27, 2021, the Offer now implies aggregate consideration to IPL shareholders of approximately C$17 per share (based on prorating), representing a premium of 30% to IPL’s 30-day volume-weighted average share price prior to the date that Brookfield...

Continue reading

Stabilis Solutions Announces First Quarter Earnings Call

Houston, TX, April 28, 2021 (GLOBE NEWSWIRE) —  Stabilis Solutions, Inc. (OTCQX:SLNG) (“Stabilis”), a leading provider of energy transition services including hydrogen and liquefied  natural gas (“LNG”) fueling solutions, is pleased to announce that it will release its first quarter 2021 financial results on Wednesday, May 5, 2021 after the market closes. The Company has scheduled a conference call on Thursday, May 6, 2021 at 10:00 a.m. eastern time (9:00 a.m. central). Dial-in InformationUnited States & Canada: +1 877-545-0320; passcode 225377 International: +1 973-528-0016; passcode 225377 Webcast: Stabilis Solutions 1Q21 Earnings Call Replay InformationUnited States & Canada: +1 877-481-4010; passcode 40949 International:+1 919-882-2331; passcode 40949  A replay of the call will be available...

Continue reading

Versus Systems to Host an Interactive Investor Event on May 20th

Executive team to update investors via a gamified presentation on recent developments, growth strategy and the partnership with Xcite Interactive LOS ANGELES, April 28, 2021 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) (FRANKFURT: BMVB) announced today that it will host its first ever virtual investor day on Thursday, May 20th. The interactive, gamified presentation will be held on the Versus Systems website and will begin at 1:30 p.m. Pacific/ 4:30 p.m. Eastern. Versus Systems’ executive management team will make a series of presentations to investors covering recent developments, its strategies and tactics for growth in markets around the world, and details and plans for its recently announced partnership with Xcite Interactive. The presentation will be accessible via the Versus Systems website...

Continue reading

PetVivo Awarded Key Biocompatible Stent Patent by the United States Patent and Trademark Office

PetVivo Holdings, Inc.Key Biocompatible Stent PatentMINNEAPOLIS, MN, April 28, 2021 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQB:PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for pets is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a patent related to the Company’s proprietary encapsulated or coated stent systems. The broad scope of the issued claims in this patent, entitled “Encapsulated or Coated Stent Systems” provides protection for a broad range of proprietary products, including stents coated with PetVivo’s biocompatible coacervate biomaterial. PetVivo’s biomaterial technology and the claims issued in this patent provide comprehensive coverage related to biocompatible...

Continue reading

Industrial Diesel Turbocharger Market to grow at a 8.72% CAGR by 2027 | Market Research Future (MRFR)

Key companies profiled include Volkswagen AG, Mitsubishi Heavy Industries, Ltd, ABB, Rolls-Royce plc, Toyota Motor Corporation, Cummins Inc, Napier Turbochargers Ltd, Turbo Service International BV, BorgWarner Inc, and Kompressorenbau Bannewitz GmbH., among others. Pune, April 28, 2021 (GLOBE NEWSWIRE) — Industrial Diesel Turbocharger Market Analysis Market Research Future (MRFR) predicts the global industrial diesel turbocharger market to hit USD 5,892.3 million at an 8.72% CAGR from 2020 to 2027 (forecast period). The demand for industrial diesel turbochargers is expected to grow significantly during the forecast period. Rising usages of diesel turbochargers in marine, agricultural equipment, power generation, construction equipment, railways, mining equipment, and other applications drive market demand. Furthermore, the growing...

Continue reading

Red White & Bloom Closes Acquisition of Florida Operations from Acreage Holdings

TORONTO, April 28, 2021 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to announce that, further to its press release of February 25, 2021, its new subsidiary, RWB Florida LLC, has completed the acquisition of all of the issued and outstanding shares of Acreage Florida, Inc. (“Acreage Florida”) from High Street Capital Partners, LLC (the “Seller”), a subsidiary of Acreage Holdings Inc. (“Acreage”) (CSE: ACRG.A.U; ACRG.B.U) (OTCQX: ACRDF, ACRHF). RWB also completed the acquisition of certain owned and leased real estate assets used in Acreage Florida’s operations (the “Florida Real Estate”). RWB Florida is licensed to operate medical marijuana dispensaries, a processing facility, and a cultivation facility in the state of Florida. The deal also includes the sale...

Continue reading

Driven Brands Holdings Inc. Reports First Quarter Results

Delivers Positive Same-Store Sales and Strong Operating IncomeRaises Fiscal Year 2021 Guidance CHARLOTTE, N.C., April 28, 2021 (GLOBE NEWSWIRE) — Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or “the Company”) today reported financial results for the first quarter ended March 27, 2021. For the first quarter, revenue was $329.4 million, an increase of 83% versus the prior year. System-wide sales hit a record $1.0 billion, an increase of 28% versus the prior year, with 37% net store growth and an increase in consolidated same-store sales of 0.5%. Loss per share was $(0.13) for the first quarter, driven by a $(0.23) per share impact from the one-time non-cash loss on debt extinguishment from proceeds associated with the Company’s initial public offering. Adjusted earnings per share2 was $0.19, an increase of 138% versus...

Continue reading

Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and Treatment

New poll shows 83% of people with depression agree life would be easier if others could understand their depression SALT LAKE CITY, April 28, 2021 (GLOBE NEWSWIRE) — In a new nationwide poll, the GeneSight® Mental Health Monitor found that 83% of people with depression agree that life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment. “Depression is one of the most misunderstood disorders. When people misinterpret patients with depression as ‘lazy’ or ‘dramatic,’ they are vastly underestimating and misunderstanding the debilitating symptoms of major depressive disorder,” said Mark Pollack, M.D., chief medical officer for the GeneSight test at Myriad Genetics. “That is why we are working with the...

Continue reading

uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April 28, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that five data presentations, of which two are oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Virtual 2021 Annual Meeting being held May 11-14. “Our presentations at ASGCT showcase our gene therapy expertise in hemophilia and Huntington’s disease, as well as advantages of the AAV5 vector in dosing through pre-existing neutralizing antibodies,” stated Ricardo Dolmetsch, Ph.D.president of research and development at uniQure. “In addition, we look forward to presenting preclinical data demonstrating the potential of the miQURE technology used in our...

Continue reading

Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update

CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, May 5, 2021, at 8:00 a.m. ET to discuss a corporate update and results for the first quarter of 2021.Conference Call & Webcast DetailsDate: Wednesday, May 5, 2021 Time: 8:00 am Eastern TimeToll Free: (844) 348-3801International: (213) 358-0955Conference ID: 7587147Webcast: https://edge.media-server.com/mmc/p/vfqo9b5qThe live webcast of the conference call can also be accessed in the Investors section of Editas Medicine website at https://www.editasmedicine.com/. About Editas MedicineAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.